Glenmark Pharma Gets USFDA Nod for Prostate Cancer Treatment Drug
According to the company in its regulatory filing, “Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Abiraterone Acetate tablets USP, 250 mg.”